Foundation year: 2010
NACE classifier: 46,17
Turnover in the last 5 years
Thousands EUR
Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2018 to 2022.
Silv EXPO has been working on transforming fresh ideas, developments and technologies into new generation of products or services. The company has developed several innovative products for the treatment and prophylaxis of cardiovascular, respiratory, and chronic hepatic diseases. Several in vitro and in vivo studies have been carried out in close cooperation with scientists, researchers and health care professionals, as well as a clinical study to find the most effective dosages and compound combinations of Latvian spruce and pine needle active substances. We’re also working on Nano-technological solutions for the inclusion of active substances into Nanosomes to result into the most effective pharmaceutical products.
Export volume over the last 5 years
Thousands EUR
Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2018 to 2022.
Main markets
- 1. Bulgaria
Target Markets
- 1. Bulgaria
- 2. Singapore
- 3. Vietnam
In which areas are looking for cooperation
- Other professional, scientific and technical services
- Pharmaceutical products
- Manufacturing of active pharmaceutical ingredients and pharmaceuticals
- Education and scientific research
Investing in R&D
Thousands EUR
Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2018 to 2022.
Products
Showing similar companies
By provided services
- Contract manufacturing
- Contract manufacturing
- Development of active pharmaceutical ingredients and pharmaceutical intermediates
- Development of finished formulations
- Distribution
- Education
- IT solutions
- Manufacturing
- Other
- Packaging and labelling
- Product formula development
- Quality control and assurance
- Sales
- Scientific research
- Serialization
- Storage
By the industry in which it operates
Foundation year: 2010
NACE classifier: 46,17
Turnover in the last 5 years
Thousands EUR
Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2018 to 2022.
2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
n/a | 14421 | 9666 | 32071 | n/a |
In which areas are looking for cooperation
- Other professional, scientific and technical services
- Pharmaceutical products
- Manufacturing of active pharmaceutical ingredients and pharmaceuticals
- Education and scientific research
Export volume over the last 5 years
Data are not able
Data are not able
Main markets
- 1. Bulgaria
Target Markets
- 1. Bulgaria
- 2. Singapore
- 3. Vietnam
Investing in R&D
Thousands EUR
Source: Data collected by the Association of Latvian Chemical and Pharmaceutical Entrepreneurs from 2019 to 2023.
2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
n/a | n/a | 9666 | 32097 | n/a |
SILV EXPO SIA
Description about enterprise:
Silv EXPO has been working on transforming fresh ideas, developments and technologies into new generation of products or services. The company has developed several innovative products for the treatment and prophylaxis of cardiovascular, respiratory, and chronic hepatic diseases. Several in vitro and in vivo studies have been carried out in close cooperation with scientists, researchers and health care professionals, as well as a clinical study to find the most effective dosages and compound combinations of Latvian spruce and pine needle active substances. We’re also working on Nano-technological solutions for the inclusion of active substances into Nanosomes to result into the most effective pharmaceutical products.